Institute of Clinical Epidemiology and Biometry, University of Würzburg, Josef-Schneider-Straße 2/D7, 97080, Würzburg, Germany.
Institute for Hygiene and Microbiology, University of Würzburg, Josef-Schneider-Straße 2/E1, 97080, Würzburg, Germany.
Clin Res Cardiol. 2018 Sep;107(9):737-744. doi: 10.1007/s00392-018-1240-4. Epub 2018 Apr 13.
Public funding for medical research in Germany is primarily provided by the German Research Foundation (DFG) and the Federal Ministry of Education and Research (BMBF). The aim of this study was to analyze the amount of national public funding for medical research on predominant causes of death in Germany, cardiovascular diseases and neoplasms, in relation to the burden of these diseases in Germany.
Three evaluators categorized medical research projects funded by the DFG or BMBF between 2010 and 2012 into the categories "Diseases of the circulatory system" (with subgroups "Ischemic heart diseases", "Heart failure" and "Cerebrovascular diseases") and "Neoplasms". The total amount of public funding by the national agencies was analyzed in relation to the burden of disease for the respective disease condition.
Information on national public funding for medical research of 2091 million euros was available; of those, 246.8 million euros (11.8%) were categorized being spent for research on "Neoplasms", 118.4 million euros (5.7%) for research on "Diseases of the circulatory system". This results in 362.08 euros per case of death, 16.58 euros per year of life lost (YLL) and 16.04 euros per disability-adjusted life year (DALY) for "Neoplasms" and in 113.44 euros per case of death, 8.05 euros per YLL and 7.17 euros per DALY for "Diseases of the circulatory system".
In Germany, research on cardiovascular diseases receives a lower share of national public funding for medical research compared to oncological research. These results are comparable to other European countries.
德国的医学研究公共资金主要由德国研究基金会（DFG）和联邦教育与研究部（BMBF）提供。本研究旨在分析德国针对主要死因（心血管疾病和肿瘤）的国家公共医学研究资金与这些疾病在德国的负担之间的关系。
三位评估员将 DFG 或 BMBF 资助的医学研究项目分为“循环系统疾病”（亚组为“缺血性心脏病”、“心力衰竭”和“脑血管疾病”）和“肿瘤”。国家机构的公共资金总额与相应疾病状况的疾病负担进行了分析。
共获得了 209100 万欧元的国家公共医学研究资金信息；其中，24680 万欧元（11.8%）用于肿瘤研究，11840 万欧元（5.7%）用于循环系统疾病研究。这导致肿瘤每例死亡的研究资金为 362.08 欧元，每丧失 1 年生命的研究资金为 16.58 欧元，每残疾调整生命年的研究资金为 16.04 欧元；心血管疾病每例死亡的研究资金为 113.44 欧元，每丧失 1 年生命的研究资金为 8.05 欧元，每残疾调整生命年的研究资金为 7.17 欧元。
与肿瘤研究相比，德国心血管疾病研究在国家公共医学研究资金中所占份额较低。这些结果与其他欧洲国家相当。
